Coronavirus disease 19 (COVID-19) is a new pandemic that has affected more than 80 million people. COVID-19 is caused by a new coronavirus strain, acute respiratory syndrome coronavirus-2 (SARS-CoV-2). COVID-19 may range from asymptomatic to severe acute respiratory syndrome and coagulative disorder, causing the death of up to 3% of patients (1). However, significant differences exist between countries concerning the incidence, spread, severity, and mortality rates (2).

Hypertonic saline with xylitol and hyaluronate may shorten the viral shedding duration in asymptomatic COVID-19 positive subjects: a pilot study

I. La Mantia
Conceptualization
;
2021-01-01

Abstract

Coronavirus disease 19 (COVID-19) is a new pandemic that has affected more than 80 million people. COVID-19 is caused by a new coronavirus strain, acute respiratory syndrome coronavirus-2 (SARS-CoV-2). COVID-19 may range from asymptomatic to severe acute respiratory syndrome and coagulative disorder, causing the death of up to 3% of patients (1). However, significant differences exist between countries concerning the incidence, spread, severity, and mortality rates (2).
2021
viral shedding; symptomless COVID-19; aerosolization; topical antibiotics; hyaluronic acid; hypertonic saline; xylitol
File in questo prodotto:
File Dimensione Formato  
Hypertonic saline with xylitol and hyaluronate may shorten the viral shedding duration in asymptomatic COVID-19 positive subjects_ a pilot study.pdf

solo gestori archivio

Descrizione: LETTER TO EDITOR
Tipologia: Versione Editoriale (PDF)
Licenza: NON PUBBLICO - Accesso privato/ristretto
Dimensione 235.79 kB
Formato Adobe PDF
235.79 kB Adobe PDF   Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11769/551122
Citazioni
  • ???jsp.display-item.citation.pmc??? 4
  • Scopus 4
  • ???jsp.display-item.citation.isi??? 3
social impact